Clinical Trials Browser

Completed × Leukemia, Myeloid, Acute × bisantrene × Clear all

NCT03820908 2020-08-07

Bisantrene for Relapsed /Refractory AML

Phase 2 Completed

Other hematologic neoplasm

Leukemia, Myeloid, Acute